THE TOLL-LIKE RECEPTOR 4 LIGANDS S100A8 AND S100A9 ARE CRUCIAL FACTORS IN VIRAL CARDIOMYOPATHY  by Becher, Peter Moritz et al.
Heart Failure
E692
JACC March 12, 2013
Volume 61, Issue 10
The Toll-like recepTor 4 ligands s100a8 and s100a9 are crucial facTors in viral 
cardiomyopaThy
Poster Contributions
Poster Sessions, Expo North
Sunday, March 10, 2013, 9:45 a.m.-10:30 a.m.
Session Title: New Insights into Heart Failure Pathophysiology
Abstract Category: 16. Heart Failure: Basic
Presentation Number: 1222-293
Authors: Peter Moritz Becher, Diana Lindner, Kostantinos Savvatis, Irene Müller, Matthias Fröhlich, Thomas Vogl, Johannes Roth, Heinz-Peter 
Schultheiss, Carsten Tschöpe, Charité-Universitätsmedizin Berlin, Berlin, Germany
Background: Various Toll-like receptors (TLRs) are a part of the innate immune system and involved in cardiac immune response after viral 
infection. Potential endogenous ligands of TLRs and their function in viral myocarditis still remain unclear. In the present study we investigated the 
role of the alarmins S100A8 and S100A9, identified ligands of TLR4, in Coxsackievirus B3 (CVB3)-induced myocarditis in mice.
methods: S100A8/A9 knockout mice (S100A8/A9-/-) and their wild-type controls (WT) were infected with CVB3 to induce myocarditis. Seven days 
after viral infection left ventricular (LV) function was estimated by conductance catheter technique as well as cardiac fibrosis, inflammatory response 
and cardiac apoptosis by immunohistochemistry or PCR. In addition, we examined serum and endomyocardial expression levels of S100A8 and 
S100A9 in patients with myocarditis and controls.
results: Seven days after infection WT-CVB3 mice displayed an impaired systolic and diastolic LV function, associated with a significant increase 
in virus load, cardiac fibrosis, inflammation and cardiac apoptosis. In contrast, S100A8/A9 deficient mice showed a definite improvement in systolic 
(dP/dtmax +26%, SV +30%, SW +42%, CO +63%, EF +29%; P<0.05) and diastolic (dP/dtmin +31%, LVEDP -62%, Tau -44%; P<0.05) LV function. In 
addition, in S100A8/A9 deficient mice, virus load (P<0.05), inflammatory immune response (e.g. IL-6 2.5-fold, IL-10 2.7-fold, IL-12 2.1-fold, IFN-γ 
2.6-fold; P<0.05), cardiac fibrosis (Col I 7.5-fold, Col III 1.4-fold; P<0.05) and cardiac apoptosis (TUNEL 6.4-fold, RACK1 8.1-fold; P<0.05) could be 
normalized to levels almost similar to uninfected control animals. Exogenous substitution of homodimer S100A8 in S100A8/A9-/- mice led in turn 
to an exacerbation of CVB3-induced myocarditis. Moreover, patients with myocarditis displayed significantly increased serum and endomyocardial 
expression levels of S100A8 and S100A9 when compared to controls (P<0.05).
conclusions: The identification of S100A8 and S100A9 proteins as key factors in the pathogenicity of experimental myocarditis might offer a new 
molecular target and biomarker for treatment of viral cardiomyopathy.
